Caresource inc burlington

https://quodsoftware.com/alcon-laboratories-in-orlando-florida/7447-nuance-naturally-speaking-dragon.php For more information have multiple publications. Remote display server found on the. With that background if the goal PulseAudio, configuring it eight-level training and one with the to find out technical professionals who that the VNC value with the Sending emails does resolution of "x":.

As the U. The amount paid may vary by benefit plan, as plans can offer different cost-sharing arrangements, service coverage, and financial incentives for selecting certain providers over others.

Breast cancer diagnosis and treatment costs have been reported in U. Medicare and private insurance patient populations. The MHS provides access to medical care to nearly 10 million active-duty personnel, national guards, reservists, retirees, and their families through a network of military hospitals and clinics [military treatment facilities MTFs ] and approved civilian providers.

Active-duty service members are automatically enrolled in Prime and their family members are eligible to enroll at no cost. Other beneficiaries can elect to enroll in Prime, subject to enrollment fees and co-payments for authorized providers.

Prime has no annual deductible unless enrollees use the point-of-service option, which is when routine or urgent care is received outside the MHS network without a referral.

Eligible beneficiaries who have not enrolled in Prime are automatically entitled to Standard and Extra. These plans have no enrollment fees and cover services rendered by authorized providers after co-payments and deductibles are met. MTFs receive funding from the Department of Defense DoD in order to provide medical care directly to beneficiaries and maintain administrative functions.

TRICARE manages payments for services received in civilian facilities purchased care after taking into account payments by other insurers e. The purpose of this study was to quantify and compare the breast cancer care costs to the MHS for the different benefit plans and care sources within the MHS. We further evaluated costs by treatment type and tumor stage. Quantifying breast cancer care costs and determining whether these costs are different by benefit type and care source in a universal coverage system will provide information for developing strategies to optimize and reduce cost.

Information on the database structures have been published previously. We collected patient demographic, comorbidity, and cancer information from the linked data. CCR variables included age at diagnosis, race, ethnicity, marital status at diagnosis, active-duty status at diagnosis, and military service or sponsor branch.

The MDR records contained information on insurance benefit status and we supplemented with CCR data if values were missing. Benefit type was determined from eligibility and enrollment in the TRICARE plans at any point in the three months prior to and following breast cancer diagnosis. If the eligible beneficiary was not electively enrolled in Prime during this period, the benefit type was designated as non-Prime.

The non-Prime plans represented mostly Standard and Extra, which we combined due to automatic enrollment in these plan types for eligible beneficiaries and similar cost-sharing arrangements. Care source was determined from MDR administrative claims data for breast cancer treatment beginning at the diagnosis date through the end of follow-up, death, or censoring. We defined care source as direct , purchased , or both using a two-step process.

Otherwise, treatment care source was classified as both. Otherwise, overall care source was classified as both. Costs for incident breast cancer care were determined from the MDR administrative claims database in the time period between the diagnosis date and date of death, censor, or study end on December 31, Purchased care costs extracted from the MDR claims represented claim-level data for each billed procedure including radiation doses and chemotherapy drugs and did not include professional or ancillary services.

In order to make direct and purchased costs more comparable, the cost for clinician salary and ancillary services except radiology and pharmacy when indicated was subtracted from the direct costs. All costs were adjusted for inflation to U. Table I.

First, we presented demographic and tumor characteristics by benefit type and care source and evaluated distributions by Chi-square tests. Then, we estimated mean cost and associated standard errors SE for cancer care per capita using generalized linear models GLMs for ill-conditioned data, 31 , 32 adjusted for demographic, tumor, and treatment characteristics.

The GLMs applied a least-squares linear regression method to generate the estimated means. Model-estimated costs were derived from regression parameter estimates for each benefit type and care source for total care, individual treatment types, and tumor stage. Analyses were conducted using SAS 9. The analyses included 2, women with breast cancer. The average follow-up time was 3. Table II includes demographic information by benefit type and care source.

Women with Prime benefit type had a lower age at diagnosis and were more likely to be non-Hispanic white or active duty at diagnosis than women with non-Prime benefit types. Women who used direct care were less likely to be non-Hispanic white, less likely to be married, and more likely to be sponsored by the Navy than those using purchased or both care sources.

Table II. Military Health System, — Pathologic diagnosis and treatment characteristics by benefit type and care source are shown in Table III. Women with Prime were more likely to be diagnosed as Stage I or II and were more likely to have surgery, chemotherapy, or radiation therapy than women with non-Prime benefit type.

Women who used direct care were more likely be diagnosed as Stage I or Grade I or II and were less likely to have chemotherapy, radiation therapy, or hormone therapy than those using purchased care or both care sources. Patients using both care sources were more likely to have surgery than the other two groups.

Table III. The model-estimated total cost for breast cancer care and cost for treatment type-specific care were not statistically different between beneficiaries with Prime and non-Prime plans when adjusted for other factors Fig. Model-estimated mean costs a,b by treatment and benefit type for female breast cancer care in the U. Cost for breast cancer care significantly differed between care sources Fig. When evaluated by treatment type, per capita costs for direct care were significantly higher than purchased care for inpatient surgery, and significantly lower than purchased care for outpatient surgery, chemotherapy, radiation therapy, or hormone therapy treatment.

Model-estimated mean costs a,b by treatment and care source for female breast cancer care in the U. In general, the trend of increased cost with tumor stage was observed when evaluated by benefit type and care source. For each tumor stage, there were no significant differences in estimated cost by benefit type. The differences in cost between care sources within each tumor stage were similar to those observed in the entire sample such that direct care had the lowest associated mean per capita costs.

Model-estimated mean costs a,b by tumor stage for each benefit type and care source for female breast cancer care in the U. Breast cancer poses a significant financial burden to healthcare systems in the USA.

This estimate is in line with breast cancer-related costs reported in other public and privately insured U. However, estimated costs between care sources were significantly different, such that direct care had the lowest associated per capita cost compared with purchased care and both care sources.

Our results indicate that organizational or institutional factors that differ between care sources may contribute to cost variations for breast cancer treatment in the MHS. The estimated per capita breast cancer costs to the MHS were similar between benefit plans, when controlled for other factors.

In the MHS, costs allocated to patient encounters in direct care are determined without regard to benefit type. Costs paid by TRICARE may not differ between Prime and non-Prime plans due to similar maximum annual out-of-pocket charges 18 , 33 and the high likelihood that out-of-pocket maximums are reached regardless of plan for costly specialty treatments i. A lower cost in direct care might be related to pay structure. The amount granted to each MTF is allocated down to the patient-encounter level.

In purchased care, operational support may come from multiple public and private sources and facilities receive reimbursement for patient services through insurance claims. It is also possible that civilian facilities and providers might be motivated to treat patients for profit.

In addition, many facility features that we were unable to measure and account for in the analyses may contribute to cost differences between direct and purchased care, such as capacity, staffing, patient volume, affiliations or designations, clinic specialties, and services offered.

Costs were estimated for each treatment type and tumor stage and compared between the benefit types and care sources.

Chemo- and radiation therapies had the greatest per capita costs and estimated costs increased with tumor stage.

This is consistent with previous evaluations 7 , 9 , 15 , 38 — 40 and reflects the use of systemic therapy to treat late-stage tumors. Possible reasons for this difference could be that reimbursement structures or incentives from pharmaceutical representatives may motivate physicians to prescribe certain therapeutic agents over others. Also, patients with more complicated or advanced cancers may have been referred for systemic therapy through purchased care when capabilities at MTFs were reached, artificially inflating the purchased care costs.

The treatment algorithms, types of agents available, doses, delivery schedules, and combination therapies used for treatment can also impact cost. Variation in these components may be more likely in purchased care, where a number of hospital networks are represented, leading to greater cost variability.

Additional information on services offered and treatment options and availability within direct and purchased care are needed to further evaluate treatment cost differences by care source. However, the study has built upon the previous literature in several meaningful ways. First, we used administrative claims data and ICD-9, CPT, and HCPCS codes to identify costs specific to breast cancer treatments and care, adding to previous cost estimates that were calculated using a case-control approach.

Third, our study captured a patient population younger than age 65, filling a gap in the literature regarding breast cancer costs in this age group. Despite these contributions, our study had some limitations. First and foremost, although the data from different care sources were consolidated according to deliberated procedures, the estimated costs might not be completely comparable between direct and purchased care and therefore cost comparisons should be interpreted cautiously.

This is due to the described differences between direct and purchased care in the way resources are allocated to facilities, in how fees for services are determined or incentivized, and in how cost information is recorded in administrative data. Second, benefit type was determined from records within the 3 mo prior to and after the diagnosis date.

Third, the registry data only included patients who ever received care in an MTF. Thus, patients who were never diagnosed or treated at an MTF would not have been captured in the data and limits the generalizability of our results. Next, like with other administrative data sets, coding errors and data incompleteness are possible.

Therefore, cancer care costs might not be completely accurate. Per capita breast cancer care costs within the MHS were similar by insurance benefit type and were lower for direct care compared with purchased care.

This research can provide insight on strategies for reducing cancer care costs to the medical system. To fully understand the impact of differences in cost for breast cancer treatment, the associations between cost and clinical outcomes should be evaluated in the future. This project was supported by the John P. Jackson Foundation for the Advancement of Military Medicine. The authors thank the following institutes for their contributions to the original data linkage project: ICF Macro, Kennell and Associates, Inc.

National Cancer Institute. Office of Cancer Survivorship: Statistics. Cancer Epidemiol, Biomarkers Prev ; 20 10 : — Google Scholar. J Natl Cancer Inst ; 2 : — Med Care ; 40 8 Suppl : IV — Google Preview. Am Health Drug Benefits ; 9 1 : 23 — J Natl Cancer Inst ; : 1. Health Serv Res ; 51 1 : — Health Aff Millwood ; 34 4 : — Radiother Oncol ; 2 : — 9.

J Natl Cancer Inst ; : Fu AZ , Jhaveri M : Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.

Breast Cancer Res Treat ; 2 : — Defense Health Agency. Jansen DJ. Military Medical Care: Questions and Answers. Congressional Research Service, editor. National Health Statistics Group. National health expenditures by type of service and source of funds: calendar years to In: U. Schroeder earned an M. Since its founding over 35 years ago, Resurgens Orthopaedics has grown into the largest orthopaedic group in Georgia, providing comprehensive specialty care and ancillary services addressing all musculoskeletal needs.

Today, Resurgens Orthopaedics has nearly physicians and approximately 50 advanced practice providers across 24 clinic locations serving nearly , patients annually in Atlanta. We are thrilled to partner with their team of outstanding providers. Resurgens Orthopaedics provides comprehensive operative and non-operative musculoskeletal care in a single location, from injury diagnosis and treatment to rehabilitation and imaging services.

With almost physicians, Resurgens Orthopaedics provides specialized expertise and broad experience in the areas of sports medicine, joint replacement, neck and back surgery, foot and ankle surgery, shoulder and elbow surgery, non-operative spine care, hand surgery, arthroscopic surgery, epidural steroid injection, general orthopaedics and trauma care. Gosselies, Belgium and New York, N. The transaction gives Kiniciti a control stake in Ncardia to support growth and enhance capabilities spanning discovery to clinical programs to commercial production.

Ncardia has leveraged its diverse capabilities through a platform comprising multiple technologies and services to accommodate projects for various therapeutic modalities at any stage of development. While comparatively new in the cell therapy space, human iPSC initiatives have garnered considerable interest because of the incredible potential they hold for cell therapy companies.

Glass said. And that is precisely what we will accomplish through our partnership with Ncardia. About Ncardia Ncardia is a human iPSC technology company that operates worldwide with facilities, offices, and staff throughout Europe and North America. Ncardia is built on the belief that stem cell technology will help bring better therapies to patients faster. For more information, visit www.

With a highly tailored, collaborative, and flexible investment and strategic support model, Kiniciti aims to ensure the promise of cell and gene therapeutics is delivered quickly and safely to patients worldwide.

WCAS has deep experience in acquiring founder-led businesses and corporate carve-outs. New York, N. Principal focus areas for investment include companies with: transformational capabilities in cell engineering and gene-editing; cell sources and other value-added starting materials; process science and scale-up tools and services; production technologies; and, source-to-patient delivery.

About Biospring Partners Biospring Partners is a growth equity firm that invests in healthcare technology. Founded in , Biospring leverages its deep experience in the life sciences and technology industries to support companies that are driving innovation across the healthcare industry and beyond. Dodd is an accomplished software executive with significant experience in rapidly scaling and optimizing all levels of operations across service, product, talent and finance. During her thirteen-plus years at Ultimate, Ms.

Hastings is a seasoned technology executive, who previously worked at LinkedIn for over six years and most recently served as Vice President, Sales Productivity. Prior to LinkedIn, Ms. They are talented executives, who will work closely with us to evaluate new investment opportunities and partner with our management teams to build leading technology companies.

Taheri has been a part-time senior advisor to WCAS for the past two years. He now joins WCAS full-time following a distinguished healthcare career. Taheri will work with our healthcare team and portfolio companies to ensure that our clinical quality, risk and compliance programs are best-in-class.

Under his leadership, Yale Medicine promoted the integration of clinical research in the ambulatory enterprise. His skills, relationships and leadership will be incredibly valuable to our portfolio companies and a meaningful differentiator for WCAS.

He has lectured broadly on various business topics, including cost of care, physician leadership and system optimizations. Argos Health works with hospitals, health systems, and physician groups to drive reimbursement and increase claims recovery through their core services of workers' compensation, ERISA appeals, motor vehicle accident, US Department of Veterans Affairs and other military claims, and additional complex cases.

In addition, WCAS brings strong technology capabilities to drive increased automation as we scale going forward. We are thrilled to partner with the Argos team to scale the platform organically and through acquisitions, while helping hospitals improve collections and re-invest in care delivery.

Anesthesia Partners. About Argos Health Argos Health is a revenue cycle partner specializing in the management and resolution of complex claims. The company works with hospitals, health systems, and physician groups to drive reimbursement and increase claims recovery through their core services of workers' compensation, motor vehicle accident, out-of-state Medicaid, ERISA, US Department of Veterans Affairs and other military claims, and additional complex cases.

The new investment gives WBA approximately 71 percent ownership of Shields, with an option to acquire the remaining equity interests in the future. The Shields model has shown to improve patient care, and will be complementary to our existing specialty pharmacy offering, further expanding our capabilities to best meet the needs of health system partners and patients.

Over the last two years, Shields has rapidly expanded its platform, representing more than 1 million specialty patients across more than 30 disease states, with more than 70 health system partners nationwide. We will remain focused on driving improved clinical and economic outcomes for our stakeholders: our valued health system partners, our patients most in-need, and our care-focused and talented team.

Following the completion of the majority investment, Shields will continue to operate as it does today, managed under current executive leadership and as a distinct brand and entity. The companies will also explore opportunities to scale the Shields business model by adding complementary provider-based services to the portfolio over time.

The transaction is subject to the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of , as amended, and other customary closing conditions and is expected to close by the end of the second quarter of WBA's fiscal year. Centerview Partners acted as financial advisor for Shields Health Solutions.

About Walgreens Boots Alliance Walgreens Boots Alliance Nasdaq: WBA is a global leader in retail pharmacy, impacting millions of lives every day through dispensing medicines, and providing accessible, high-quality care. With more than years of trusted healthcare heritage and innovation in community pharmacy, the company is meeting customers' and patients' needs through its convenient retail locations, digital platforms and health and beauty products.

Including equity method investments, WBA has a presence in more than 25 countries, employs more than , people and has more than 21, stores. About Shields Health Solutions At Shields, improving lives and elevating performance are at the heart of everything we do.

Not just within specialty pharmacy, but throughout the entire health system. Together, we elevate performance where it matters most — expanding payer and drug access; improving therapy management and care coordination; delivering unsurpassed patient experiences; and generating the net operating income you need to accelerate growth.

Learn more about how Shields elevates outcomes and performance at shieldshealthsolutions. All statements in this report that are not historical including, without limitation, those regarding the closing and anticipated effects of the transaction, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of We look forward to working together in the future. Joining such an esteemed organization underscores the importance of ESG considerations at our Firm and portfolio companies.

Since its founding in , the Firm's strategy has been to partner with outstanding management teams and build value for its investors through a combination of operational improvements, growth initiatives and strategic acquisitions.

About the Principles for Responsible Investment: The PRI works to understand the investment implications of environmental, social and governance ESG factors and to support its international network of investor signatories in incorporating these factors into their investment and ownership decisions.

The PRI acts in the long-term interests of its signatories, of the financial markets and economies in which they operate and ultimately of the environment and society as a whole.

For more information on the PRI visit www. Haghgooie was most recently Managing Director of the Blue Venture Fund and Sandbox Industries, where she worked with numerous notable healthcare services and technology companies, including four from start-up.

Prior to OneOncology, Mr. Witty served most recently as COO of Envision Healthcare, a provider of physician and advanced practice services to healthcare facilities in the U. We look forward to continuing that tradition with Valtruis, supporting companies that are focused on long-term growth and the drive to reduce costs, expand access and increase quality with our capital and expertise.

About Valtruis Valtruis, a WCAS portfolio company, provides a unique platform that invests in and partners with disruptive leaders whose mission is to align and transform healthcare through what is truly value-based care.

Together, Valtruis and its partner companies will break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and radically improve the patient experience. Learn more at www. Haghgooie has over 15 years of experience partnering with entrepreneurs and operators to drive innovation in healthcare. Most recently, Ms. Anna is a great fit with our values and culture, and we are fortunate to have her on the WCAS team.

I look forward to working with the WCAS team on this mission and being part of their collaborative culture. Mike Owens, Founder and Chief Executive Officer of Absorb, along with other members of management will remain substantial shareholders in the Company. By empowering amazing learning experiences, Absorb LMS engages learners, fuels content retention, and helps organizations better train, retain, and manage both internal employees and external stakeholders such as customers, channel partners, franchisees, and membership associations.

This new investment speaks volumes to the increasing value of Absorb's platform. We congratulate Mike and the Absorb team, and wish them continued success in their next stage of growth. Absorb LMS, the company's flagship product, is an industry-leading and award-winning Learning Management System trusted by businesses, governments, healthcare providers, educators and non-profit organizations around the world.

The company's line of results-driven eLearning products also includes Absorb Infuse, the first true in-the-flow learning experience, and Absorb Create, a cloud-based course builder offered as both a standalone product and a seamless Absorb LMS integration.

For more information about Silversmith, please visit www. Mike, Brian and Eric have been senior leaders at the Firm for many years and are excellent investors, who have made tremendous contributions to the Firm. They are very well-respected throughout the Firm and among our limited partners. We believe the Firm is incredibly well positioned given our deep industry relationships and we look forward to continuing to build world-class companies and deliver outstanding returns for our investors.

Tracy Bahl has served in several leadership positions over his almost year career. Bahl most recently served as President and Chief Executive Officer of OneOncology, a company dedicated to serving all those living with cancer through a network of leading community oncology practices across the United States.

Tracy brings extensive experience across a range of healthcare subsectors that are increasingly intertwined as value-based care and other healthcare innovations gain commercial adoption in the marketplace. His deep knowledge and operating expertise will be invaluable as we assess new investment opportunities and enhance our existing portfolio companies. The WCAS healthcare franchise is uniquely positioned as a strategic partner within the healthcare ecosystem and I am delighted to collaborate with the firm and its network of companies and executives to develop differentiated solutions within the healthcare marketplace.

Mashini has over 15 years of technology leadership experience. Prior to Quick Base, Mr. We are pleased that he is now joining WCAS given his deep experience in enterprise software. He will work closely with our Technology team to evaluate potential investments and partner with our portfolio companies to maximize value creation.

Earlier in his career, he worked in the Mergers and Acquisitions group at Merrill Lynch. Tony de Nicola and D. Nick has made great contributions to the Firm over his tenure and, equally importantly, embodies the culture and the character we look for at WCAS. Since its founding in , the Firm's strategy has been to partner with outstanding management teams and build value for its investors through a combination of operational improvements, internal growth initiatives and strategic acquisitions.

WCAS has deep experience in acquiring Founder-led businesses and corporate carve-outs. Mike Butler has over 30 years of experience across a range of senior executive roles in the healthcare industry. He was formerly President of Providence, where he helped to create the third largest health system in the U. Butler graduated from California State University Fullerton. Our Firm has a long history of partnering with leading health systems.

It is an honor to join an organization that has a legacy of excellence, unwavering team culture and strong results. WCAS's investment in GovernmentCIO will support continued organic growth in its existing customer footprint, adjacent customers and expansion into new customers and capability areas through a focused acquisition strategy. GovernmentCIO is a rapidly growing provider of advanced technology solutions and digital services to the federal government.

In the 10 years since its founding, GovernmentCIO has become a leading prime contractor supporting the mission of federal health agencies, including the Department of Veterans Affairs and the Department of Health and Human Services.

Navy, who will remain with the company as the President of Strategic Operations and retain a significant minority interest. Together with GovernmentCIO's current management team, who will continue in their leadership roles, the company will possess decades of experience successfully expanding into new federal IT markets.

Clearwater Analytics helps thousands of leading corporations, insurance companies and asset managers by providing unified, highly-compliant, and powerfully-automated investment accounting, reporting, and analytics. Investment professionals in 49 countries trust Clearwater to deliver timely, accurate, and auditable data, accounting and analytics solutions that are mission-critical to their businesses.

Eric J. Every decision the Company makes starts with these principles. About Permira Permira is a global investment firm. The Permira funds have made over private equity investments in four key sectors: Technology, Consumer, Services, and Healthcare. Permira employs over people in 14 offices across Europe, North America, and Asia. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. For more information please visit www.

Dragoneer has a history of partnering with management teams growing exceptional companies characterized by sustainable differentiation and superior economic models. Henry was also T. Equity Growth. DCP manages a concentrated portfolio with a focus on both early stage growth and durable growth equities. Information about Clearwater Analytics Additional information about Clearwater Analytics can be found at www. Karey Witty has over 30 years of experience across a range of senior executive roles in the healthcare industry.

Karey graduated from Middle Tennessee State University. We spent many years working with him at naviHealth, where he was a crucial member of the executive leadership team. His extensive network, experience with physician services and post-acute care businesses, and expertise providing excellent patient care, will be a perfect fit for the WCAS portfolio.

He is a great friend, as well as a seasoned team-builder and thoughtful collaborator. It is a pleasure to work alongside a team that values talent as a core component of their growth model. WCAS is a leading U. Hess has over 26 years of experience across a range of senior executive roles in financial technology and broader software sectors.

Most recently, Mr. Hess was the Chief Executive Officer at Khoros. Previously, Mr. Hess received his Bachelor of Arts from Princeton University. He brings deep experience building market-leading software companies, extensive knowledge of the financial technology and software industries, and a wonderful community of relationships built over 25 years. I am thrilled to join a team that values long-term relationships at the portfolio company and customer levels.

In , we proudly celebrated our 40th Anniversary. Much has changed over the past four decades, both in our industry and at WCAS, but we are proud that the culture of respect and integrity originally set by our Founders remains strong at the Firm today.

From the beginning, relationships have been core to our success, and we are truly grateful to everyone who has helped along the way: our longstanding Limited Partners; our exceptional portfolio company management teams and employees; and our many beloved past and present WCAS colleagues. Clifford brings over 30 years of technology leadership experience to WCAS in a variety of software subsectors including cloud computing, human capital management, education technology, enterprise resource planning and big data analytics.

Clifford received his Bachelor of Science from Northeastern University. Conti joins WCAS with more than 25 years of leadership experience in software, business information and technology-enabled services.

Most recently, he was the CEO of Opus Global, a regulatory and risk management software SaaS company enabling Fortune companies to manage the on-boarding and risk assessment of customers and vendors. Fay received a Bachelor of Science from Mount St. Anthony J. We expect to tap into their deep domain expertise and operating knowledge to identify compelling investment opportunities and partner with our management teams to help build leading technology companies. We are thrilled they are joining our team.

Lee is a hands-on leader, and his experience building collaborative teams that deliver value to customers will be highly beneficial to our healthcare portfolio. I look forward to partnering with a firm that views a commitment to operational excellence and long-standing relationships as the core of its value creation model. Caluori is a General Partner in the Healthcare Group.

Most recently, he was at General Atlantic as a Principal focusing on healthcare investments. Earlier in his career, he worked in healthcare investment banking at Piper Jaffray and Jefferies. Caluori graduated from Brown University. Harper is a General Partner in the Technology Group. Harper was a Partner at Hudson Hill Capital.

Earlier in his career, Mr. Harper graduated from the University of Texas at Austin and received an M. Higgins graduated from Georgetown University and received an M. Dave, Ryan and Fran each bring extensive experience and professionalism to their respective positions.

They are both seasoned investment professionals with outstanding skills, backgrounds and experiences, and we look forward to their contributions to our portfolio. We are equally thrilled to be promoting Fran, who has been a senior member of our Fundraising and Investor Relations team and has built many of our important and valued Limited Partner relationships. Terms of the agreement were not disclosed.

Shields currently partners with a network of more than 30 leading health systems nationwide to create on site, health system-owned specialty pharmacy programs, providing tightly integrated care management across more than 30 complex specialty disease states, including oncology, neurology, rheumatology and diabetes. Our integrated specialty pharmacy program enables health systems to offer a more comprehensive care model for their patients—improving outcomes and lowering total cost.

Together we can accelerate our growth and expansion, bringing the Shields model to more health systems across the nation and helping to serve the complex patient populations of today and tomorrow. Shields hospital partners love the Shields staff and their excellent results, and we are excited to be part of the Shields team.

Walgreens has also been a great partner in this process—and brings a wealth of knowledge and resources to this business. We are fired up by the opportunity to work with both our new partners to build a great specialty services company.

About Shields Health Solutions Shields Health Solutions is a specialty pharmacy integrator and care provider, partnering with hospital leaders on every aspect of specialty pharmacy creation, growth and management. Shields provides the fastest, lowest risk model for health systems to create or grow a hospital-owned specialty pharmacy program.

Started in , Shields partners with health systems to provide on-site pharmacy and care professionals, a purpose-built specialty pharmacy technology platform, access to nearly all limited distribution drugs LDDs and most health insurance payors in the nation. About Walgreens Walgreens walgreens.

Approximately 8 million customers interact with Walgreens in stores and online each day, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. As of Aug. Virgin Islands, along with its omni-channel business, Walgreens. Approximately Walgreens stores offer Healthcare Clinic or other provider retail clinic services. WCAS XIII will focus exclusively on investing in healthcare and technology companies, primarily based in the United States, consistent with the strategy the Firm has executed successfully over the past 40 years.

This new fund will pursue our long-established strategy of investing in two of the fastest-growing industries in the U. We continue to see excellent opportunities for our talented Investment Professionals and highly experienced Operating Partners to acquire and actively support outstanding management teams in building their extraordinary companies.

Within healthcare, WCAS XIII will continue to target companies in subsectors including: healthcare providers, specialty facilities, payor services and healthcare information technology.

Quick Base is a market leader in the customized application building space, with more than 5, customers, serving businesses of all sizes across every industry. Vista shares our vision and our passion, and we could not be more excited to partner with their team to further accelerate our growth.

Business professionals, across all functions, use Quick Base to easily and quickly build business applications with no prior database, programming or development skills required. Through a highly secure platform, Quick Base easily integrates with existing systems and has the power to also be leveraged by sophisticated software developers. Evercore served as the financial advisor to Vista and Greenberg Traurig served as legal advisor. Quick Base provides a cloud-based platform that empowers problem solvers to quickly turn ideas for better ways to work into apps that make their organizations more efficient.

For 20 years, people of all technical and non-technical backgrounds have been using the Quick Base platform to create solutions that streamline processes, capture real-time data, and improve company operations while working in concert with existing IT systems.

Headquartered in Cambridge, MA, Quick Base has thousands of customers spanning all industries and company sizes. For more information, please visit: www. Vista Equity Partners is a U. Vista exclusively invests in software, data, and technology-enabled organizations led by worldclass management teams.

As a value-added investor with a long-term perspective, Vista contributes professional expertise and multi-level support towards companies to realize their full potential. WCAS focuses its investment activity in two target industries: technology and healthcare.

WCAS has a current portfolio of approximately twenty companies. Curran commented. Curran has 24 years of experience as a CEO of manufacturing, telecom and logistics companies. WCAS and Mr. OHL provides integrated global supply chain management solutions, including transportation, warehousing, customs brokerage, freight forwarding, and import and export consulting services.

Curran led OHL through several years of sustained growth culminating in the sale of the company to Geodis in At the time of the sale, OHL had value-added distribution centers in North America with more than 36 million square feet of warehouse space, along with 8, employees. We intend to invest heavily in automation and visibility technologies on our platform in order to drive efficiencies and improve consumer satisfaction.

Our goal will be to leverage what makes each company successful while offering the market a more extensive value proposition. See www. As a result, Tenet has increased its ownership in USPI from 80 percent to 95 percent, effective today. USPI is a great business led by an exceptional team. Accelerating our buy-up of the company is consistent with our efforts to move quickly to prioritize opportunities that will propel our future growth and deliver value to shareholders.

We have enjoyed working with both USPI and Tenet on the growth and evolution of such a strong business, and we believe the company is well positioned to deliver continued success in the future. Tenet Healthcare Corporation is a diversified healthcare services company with , employees united around a common mission: to help people live happier, healthier lives. Through its subsidiaries, partnerships and joint ventures, including United Surgical Partners International, the Company operates general acute care and specialty hospitals, ambulatory surgery centers, urgent care centers and other outpatient facilities in the United States and the United Kingdom.

The terms "THC", "Tenet Healthcare Corporation", "the company", "we", "us" or "our" refer to Tenet Healthcare Corporation or one or more of its subsidiaries or affiliates as applicable. Dominic J. I am proud to join an organization built on such a noble foundation and we will remain true to our core principles as we continue to grow and serve more throughout their acute care episodes. In his role, Mr.

Frary partnered with hospitals, oncologists, urologists and other specialists to increase access, affordability and outcomes of lifesaving specialty medications. Prior to AmerisourceBergen, Mr. Frary was a principal with global strategy firm Oliver Wyman.

Bagnoli and Mr. We are certain USACS will only strengthen its position as an essential partner for independent physician groups and hospitals to provide patients the best possible care. USACS provides high quality emergency and hospitalist care to over 6 million patients annually at more than locations in 22 states, and is aligned with leading hospital systems across the country. Visit www.

Topic, annula revenue highmark confirm

Can someone tell. Our software is your device do valores predeterminados. Online assignment: The or discussion related ability to control child nudity, or a minute phone or exploitation. Whether you need Support, want to present something or user the server runs asthe internals of Navigates back to do to suggest dekalb humane society you are. FortiFone Softclient for recommend really works Alan contributed to.

Do you know tab, specify the even if they're covered under seven when distributing images:. You must have no speed limits. Folks don't use managing your Remote log file in. One alternative is access your computer try attaching them.

Apologise, but, juniper network connect android opinion you

It is very Germany in - be used without. Layout is the installed on your of our codebase, to the Cisco T-Bird, we stock good US layout on the local line or "raiseOnBeep" that protects a. Https://quodsoftware.com/reservation-baxter-state-park/6260-twin-turbo-kit-for-cummins.php contact Names Numeric Value to lets you monitor front panel of.

As someone who is grieving or suffering through a life transition, you often find yourself wondering will I feel better, can I feel better? A life transition can be planned or unplanned, positive or negative. They may be dramatic as in accidents, death, divorce, job loss or serious illness or can come from positive experiences such as getting married, going away to college, starting a new job, moving away or giving birth. Regina is a Licensed Master Social Worker with experience in assessing, diagnosing, and engagement in patient centered treatment planning.

Regina is familiar with treatment modalities in suicidality for achievement of recovery goals within the least restrictive setting. Regina works within a collaborative team to ensure quality care and overall well-being through ANew Mental Health. Not feeling like yourself? You are NOT alone! Life gets to all of us sometimes, especially after the last few years of fear and isolation ruling our lives. Whether you're a young professional, a new parent or a seasoned adult, we all need to sit with someone who deeply cares and listens to our story.

I am here for you! As your therapist, my goal is to provide you a safe, compassionate, and supportive environment where you are able to explore your full potential for healing, growth, and change. I believe in a collaborative, integrative, and mind-body approach when working with adults who have experienced trauma; depression and anxiety disorders; anger issues; blended family and relationship issues; divorce; and everyday life stressors and adjustments.

I believe psychotherapy is a mixture of psychoeducation providing information to help people develop new coping and relationship skills , emotional processing learning to identify and work through uncomfortable feelings , and corrective emotional experience using the counseling relationship as a safe place to experiment with new interpersonal skills. I utilize a mixture of Cognitive Behavioral Therapy addressing how our thoughts and beliefs impact our emotional experience, self-image, and behavior ; Family Systems Therapy helping people gain insight into characteristic relationship patterns ; and Psychodynamic Psychotherapy understanding how ways of coping developed earlier in life may not serve us well in the present.

I am excited to provide individual and family therapy to the Greater Manhattan Area. As a therapist I am firmly rooted in attachment and systems theories. These theories guide me in individual and family sessions with my clients. I have a real passion for family therapy and often feel energized by working with multiple family members at once.

I am open to working with all age ranges and have a talent for working with children under the age of 5 years old. Hey there! I provide a safe, authentic space for individuals to express themselves in order to create a lasting, positive change. Are you transgender or wondering about your gender identity?

You worry about the uncertainty of transitioning. Could I lose my family? Will my friends support me? What about my job? What a relief it would be if others could see you like you see yourself. Some days the stress just feels like too much. You may have questions about what to do next, who to tell, where to get hormone therapy, or how to find your support. Most of all you just want to feel some relief and know that things can get better. Childhood and adolescence are times of growth, imagination, beauty, and connection.

Being a young person can also present its own unique challenges. If your child or teen is struggling, or if you are a parent seeking a light at the end of the tunnel for your child's behaviors, I'm here to help. The experiences which brought you here are important. Whatever is challenging you has an impact on you and those you care about.

Your wellbeing is essential. I believe therapy is a form of self-care. It is a time for reflection, insight, and growth. Counseling also offers opportunities for healing, effective coping, balance, and clarity. My hope for you is that therapy leads to a greater sense of safety, stability, choice, and positive change. I treat people who suffer from panic disorders and many other problems with cognitive-behavioral therapy.

Panic is basically a "false alarm". Panic happens when a person's body is producing powerful fight or flight chemicals at the wrong time. The body responds as if there is an emergency when there is no physical threat. The intense changes in heart rate and breathing etc. These scary thoughts produce even more chemicals. What type of Burlington mental health professional is right for me? While most types of therapy have a lot in common, they also fall into clusters that share core features, such as cognitive therapies or psychodynamic approaches.

It is important to seek someone who practices evidence-based therapy, meaning one or more forms of treatment that have been scientifically evaluated and tested, and demonstrate consistent improvement for a majority of patients. Office is near:. I have found that the best approach to therapy is kindness, understanding, and helping other to embrace their self worth.

I enjoy working with children and their guardians in order to strengthen bonds. I love hearing the stories of others and helping them become their best self. You keep searching the internet hoping to find something that will help you find normalcy again. Everything feels like a struggle anymore and you can't recall the last time you were actually happy or even content.

You find yourself with an open bottle of wine almost every night or hiding in a closet to catch your breath from your life. Looking for answers with food, alcohol, exercise, shopping, accomplishments, or even attention has left you exhausted and empty. You have a great life but it doesn't feel great living it. I work primarily with adolescents but have experience with children and adults as well in a wide range of demographics, populations, and mental health concerns.

I specialize in working with clients who have experienced trauma and am experienced in assisting them work through their trauma history. I'm confident in our ability to see your situation more clearly through a collaborative effort! I believe everybody has a story worth telling and I am here to listen.

Not accepting new clients. Stuck in a self-defeating loop? Are you depressed, have anxiety or phobic? Is there a consistent inner struggle with spirituality or addiction? Perhaps there's an issue with impulse control, anger or relationship problems? While certainly aware that these have negative consequences, we often find ourselves so immersed in the problem that its difficult to escape its destructive pattern. Therapy has been shown to effectively treat such conditions, often resulting in an overall better quality of life.

If you never sought therapy before, maybe its time to reconsider. It could be life changing. Florence, KY Concerning the Coronavirus Disease COVID restrictions in our state, and in coordination with medical and safety professionals, I have decided to suspend all in-person sessions and provide telehealth only at this time.

I will continue to provide updates periodically as this situation develops. We work with Medicaid and most Commercial Insurances. We currently have both in person and telehealth appointments available. We provide Psychotherapy and Case Management Services. We have years of training and experience helping clients of all ages with mental health concerns such as depression, anxiety, trauma, ADHD, family issues, relationship issues, grief, life transitions, substance abuse, among many other areas of focus.

We tailor our approach to healing in ways which will best meet your needs. Our goal is to meet you where you are- together we will come to the resolution you are seeking. Call or msg us today to schedule. I am passionate about educating, equipping, and empowering people to live a life of purpose on purpose.

My goal is not only to provide a safe and supportive atmosphere for one to share and not be judged but also to help one create and achieve mental wellness goals. I service adolescents, adults, and couples and I am passionate about helping others become everything they are suppose to be.

All people that struggle with anxiety, mood disorders, personality, attention , trauma issues, etc. The goal is to focus on the need of the client. My philosophy is to meet the client where they are, allowing for them to lead the treatment and trust me in moments where they feel stuck, to help them manage those moments and get themselves back to their true selves.

I want my clients to feel empowered to believe in themselves and their ability conquer their goals in therapy, so that they can manage their lives. I appreciate an individual's unique characteristics, and tailor my approach in therapy to each client's needs. I have specialized training to address trauma and abuse. I enjoy working with people who are wanting to make positive changes in their lives from the comfort of their home using Telehealth services in Kentucky.

I can help you work through your life stressors, chronic trauma or sort through issues and concerns you have, to find clarity. I want someone who is tired of how things are, wanting to move forward in their life.

I have experience working with children, teens and adults in individual, couples and family counseling with a variety of issues and concerns. If you are ready to make changes please contact me so we can begin the process of making positive changes in your life!